Latest News
MEDIPOST files IND amendment to start Phase III trial for knee osteoarthritis therapy
13 February 2026 - Biotechnology company MEDIPOST Inc said on Friday that it has submitted an Investigational New Drug (IND) amendment to the US Food and Drug Administration (FDA) to support the initiation of a Phase III clinical trial evaluating its...
AstraZeneca reports positive Phase III results for BREZTRI in uncontrolled asthma
13 February 2026 - Biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (NYSE:AZN) reported on Friday that full results from the Phase III KALOS and LOGOS trials, published in The Lancet Respiratory Medicine, show that AstraZeneca's BRE...
Hoth Therapeutics granted US patent for novel exon-skipping therapy targeting allergic diseases
13 February 2026 - US biopharmaceutical company Hoth Therapeutics Inc (NASDAQ:HOTH) announced on Thursday that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for 'Exon Skipping of FC-Epsilon-RI-Beta and MS...
Centivax Inc doses first healthy volunteers in Centi-Flu 01 Phase 1A clinical trial
13 February 2026 - Clinical-stage biotechnology company Centivax Inc announced on Thursday that the first participants have been dosed in the company's Phase 1A clinical trial evaluating Centi-Flu 01, a pan-influenza universal flu vaccine, in he...
Pegasus Laboratories' KBroVet receives full FDA approval for control of seizures associated with IE in dogs
13 February 2026 - Pharmaceutical development and manufacturing company Pegasus Laboratories Inc announced on Thursday that it has received full approval from the US Food and Drug Administration (FDA) for KBroVet (potassium bromide chewable tablets) ...